364 related articles for article (PubMed ID: 26508273)
1. The role of miRNAs in cutaneous squamous cell carcinoma.
Yu X; Li Z
J Cell Mol Med; 2016 Jan; 20(1):3-9. PubMed ID: 26508273
[TBL] [Abstract][Full Text] [Related]
2. MiR-21 and miR-205 are induced in invasive cutaneous squamous cell carcinomas.
Stojadinovic O; Ramirez H; Pastar I; Gordon KA; Stone R; Choudhary S; Badiavas E; Nouri K; Tomic-Canic M
Arch Dermatol Res; 2017 Mar; 309(2):133-139. PubMed ID: 28013372
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA Dysregulation in Cutaneous Squamous Cell Carcinoma.
García-Sancha N; Corchado-Cobos R; Pérez-Losada J; Cañueto J
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31052530
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of LINC00319 indicates a poor prognosis and promotes cell proliferation and invasion in cutaneous squamous cell carcinoma.
Li F; Liao J; Duan X; He Y; Liao Y
J Cell Biochem; 2018 Dec; 119(12):10393-10405. PubMed ID: 30145798
[TBL] [Abstract][Full Text] [Related]
5. MiR-199a inhibits the ability of proliferation and migration by regulating CD44-Ezrin signaling in cutaneous squamous cell carcinoma cells.
Wang SH; Zhou JD; He QY; Yin ZQ; Cao K; Luo CQ
Int J Clin Exp Pathol; 2014; 7(10):7131-41. PubMed ID: 25400809
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-125b down-regulates matrix metallopeptidase 13 and inhibits cutaneous squamous cell carcinoma cell proliferation, migration, and invasion.
Xu N; Zhang L; Meisgen F; Harada M; Heilborn J; Homey B; Grandér D; Ståhle M; Sonkoly E; Pivarcsi A
J Biol Chem; 2012 Aug; 287(35):29899-908. PubMed ID: 22782903
[TBL] [Abstract][Full Text] [Related]
7. Role of miR-148a in cutaneous squamous cell carcinoma by repression of MAPK pathway.
Luo Q; Li W; Zhao T; Tian X; Liu Y; Zhang X
Arch Biochem Biophys; 2015 Oct; 583():47-54. PubMed ID: 26253263
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-664 functions as an oncogene in cutaneous squamous cell carcinomas (cSCC) via suppressing interferon regulatory factor 2.
Li X; Zhou C; Zhang C; Xie X; Zhou Z; Zhou M; Chen L; Ding Z
J Dermatol Sci; 2019 Jun; 94(3):330-338. PubMed ID: 31138473
[TBL] [Abstract][Full Text] [Related]
9. miR-193b/365a cluster controls progression of epidermal squamous cell carcinoma.
Gastaldi C; Bertero T; Xu N; Bourget-Ponzio I; Lebrigand K; Fourre S; Popa A; Cardot-Leccia N; Meneguzzi G; Sonkoly E; Pivarcsi A; Mari B; Barbry P; Ponzio G; Rezzonico R
Carcinogenesis; 2014 May; 35(5):1110-20. PubMed ID: 24374827
[TBL] [Abstract][Full Text] [Related]
10. MiR-1193 was sponged by LINC00963 and inhibited cutaneous squamous cell carcinoma progression by targeting SOX4.
Wang J; Li C; Xu L; Yang C; Zhang X
Pathol Res Pract; 2019 Oct; 215(10):152600. PubMed ID: 31477326
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA SCARNA2 induces cutaneous squamous cell carcinoma progression via modulating miR-342-3p expression.
Zhang Z; Jia M; Wen C; He A; Ma Z
J Gene Med; 2020 Dec; 22(12):e3242. PubMed ID: 32558970
[TBL] [Abstract][Full Text] [Related]
12. Alterations of microRNAs throughout the malignant evolution of cutaneous squamous cell carcinoma: the role of miR-497 in epithelial to mesenchymal transition of keratinocytes.
Mizrahi A; Barzilai A; Gur-Wahnon D; Ben-Dov IZ; Glassberg S; Meningher T; Elharar E; Masalha M; Jacob-Hirsch J; Tabibian-Keissar H; Barshack I; Roszik J; Leibowitz-Amit R; Sidi Y; Avni D
Oncogene; 2018 Jan; 37(2):218-230. PubMed ID: 28925390
[TBL] [Abstract][Full Text] [Related]
13. Microarray analysis of microRNA expression in cutaneous squamous cell carcinoma.
Sand M; Skrygan M; Georgas D; Sand D; Hahn SA; Gambichler T; Altmeyer P; Bechara FG
J Dermatol Sci; 2012 Dec; 68(3):119-26. PubMed ID: 23026055
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA expression differs in cutaneous squamous cell carcinomas and healthy skin of immunocompetent individuals.
Bruegger C; Kempf W; Spoerri I; Arnold AW; Itin PH; Burger B
Exp Dermatol; 2013 Jun; 22(6):426-8. PubMed ID: 23711067
[TBL] [Abstract][Full Text] [Related]
15. MiR-204 silencing in intraepithelial to invasive cutaneous squamous cell carcinoma progression.
Toll A; Salgado R; Espinet B; Díaz-Lagares A; Hernández-Ruiz E; Andrades E; Sandoval J; Esteller M; Pujol RM; Hernández-Muñoz I
Mol Cancer; 2016 Jul; 15(1):53. PubMed ID: 27457246
[TBL] [Abstract][Full Text] [Related]
16. Loss of BAX by miR-365 Promotes Cutaneous Squamous Cell Carcinoma Progression by Suppressing Apoptosis.
Zhou L; Gao R; Wang Y; Zhou M; Ding Z
Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28556798
[TBL] [Abstract][Full Text] [Related]
17. miR-497 promotes the progression of cutaneous squamous cell carcinoma through FAM114A2.
Wei XH; Gu XL; Zhou XT; Ma M; Lou CX
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7348-7355. PubMed ID: 30468480
[TBL] [Abstract][Full Text] [Related]
18. Circular RNA expression in cutaneous squamous cell carcinoma.
Sand M; Bechara FG; Gambichler T; Sand D; Bromba M; Hahn SA; Stockfleth E; Hessam S
J Dermatol Sci; 2016 Sep; 83(3):210-8. PubMed ID: 27298156
[TBL] [Abstract][Full Text] [Related]
19. miR-506 contributes to malignancy of cutaneous squamous cell carcinoma via targeting of P65 and LAMC1.
Zhou J; Zhang Y; Han Z; Dong Z; Cao T; Wei A; Guo P; Meng Q
Cell Cycle; 2019 Feb; 18(3):333-345. PubMed ID: 30646812
[TBL] [Abstract][Full Text] [Related]
20. UV-type specific alteration of miRNA expression and its association with tumor progression and metastasis in SCC cell lines.
Chen IP; Bender M; Spassova I; Henning S; Kubat L; Fan K; Degenhardt S; Mhamdi-Ghodbani M; Sriram A; Volkmer B; Boukamp P; Becker JC; Greinert R
J Cancer Res Clin Oncol; 2020 Dec; 146(12):3215-3231. PubMed ID: 32865618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]